
CannaPharmaRx Inc
OTC:CPMD

Net Margin
CannaPharmaRx Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | Company | Market Cap |
Net Margin |
||
---|---|---|---|---|---|
CA |
![]() |
CannaPharmaRx Inc
OTC:CPMD
|
2.1m USD |
408%
|
|
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
663.9B USD |
26%
|
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
-4%
|
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
424.9B USD |
25%
|
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
203.6B CHF |
14%
|
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
179.8B GBP |
15%
|
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
192.2B CHF |
25%
|
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
36%
|
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
211.9B USD |
26%
|
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
183.4B USD |
-126%
|
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
142.9B USD |
17%
|
CannaPharmaRx Inc
Glance View
CannaPharmaRx, Inc. engages in the research and manufacture of cannabinoid-based pharmaceuticals. The company is headquartered in Calgary, Alberta and currently employs 4 full-time employees. The principal activity of the Company is to negotiate, acquire and develop various cannabis cultivation projects throughout Canada. The firm's activities is centered around projects, such as the Great Northern Project, and the acquisition of Ramon Road Production Campus LLC. The firm is focused on producing wholesale cannabis and hemp for the medical market.

See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on CannaPharmaRx Inc's most recent financial statements, the company has Net Margin of 408.3%.